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Abstract
Background: Modifications of the histone amino-terminal tails affect access of regulatory factors and complexes to
chromatin and thereby influence biological processes. Cancer cells are characterized by prominent epigenetic
dysregulation, including histone modifications. However, the functional roles of the histone methyltransferases (HMT) in
cancer remain unclear.
Methodology/Principal Findings: We studied RNAi-based inhibition (knockdown, KD) of 2 different H3K9 HMTs, SUV39H1
and G9a. Knockdown of the 2 HMTs in PC3 cancer cell line markedly inhibited cell growth and caused profound
morphological changes with loss of telomerase activity and shortened telomeres. SUV39H1 KD cells showed substantial
increase in G2/M fraction. G9a KD cells showed increased DNA content (1.7-fold in 2 independent clones) compared with
FACS analyses to control. Karyotype analyses showed that this was due to an increased number of chromosomes (from 61
to 102) in G9a KD cells compared to parental PC3. Intriguingly, we found abnormal centrosome morphology and number in
about 25% of the G9a KD cells, while centrosomes were morphologically normal in control cells. Microarray analyses after
KD of SUV39H1 or G9a showed very few genes up-regulated among the 39,000 genes. The silenced tumor-suppressor genes
p16 and RASSF1A were not activated in KD cells.
Conclusions/Significance: These data suggest that the 2 HMTs, SUV39H1 and G9a are required to perpetuate the malignant
phenotype. Furthermore, G9a plays a critical role in regulating centrosome duplication presumably through chromatin
structure rather than through affecting gene expression in cancer cells. Targeting these histone methyltransferases may be
of therapeutic benefit in cancers.
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Introduction
Chromatin assembly is a critical process related to DNA
replication, gene expression and progression through the cell cycle.
Specific modifications are associated with certain DNA template-
mediated processes [1]. Methylation of histone H3 lysine 9 (H3K9)
is one of the most well-studied histone modifications. After the
initial identification of SUV39h1 in addition to the highly related
SUV39h2 as a H3K9-specific histone methyltransferase (HMT)
[2], at least three other HMTs, G9a, ESET/SETDB1 and
EuHMTase1, have been recognized as HMTs for H3K9 in
mammals [3–5]. These enzymes have different affinities for the
un-, mono- or dimethylated states and produce different
methylation states. Studies in knockout mice for Suv39h1, 2 and
G9a revealed that G9a is mainly responsible for monomethylation
(1Me) and dimethylation (2Me) of H3K9, whereas Suv39h1 and
Suv39h2 direct trimethylation (3Me) of H3K9. Furthermore, 1Me
and 2Me on H3K9 primarily reside in euchromatin, while 2Me
and 3Me on H3K9 are found within different types of
heterochromatin, facultative and constitutive heterochromatin,
respectively. These results suggest that 1Me, 2Me, or 3Me at
K9H3 occupy distinct chromosome domains and each of the three
states of H3K9 methylation plays a unique role in the structural
and functional organization of chromosomes.
Regulation of higher-order chromosome structure affects
mitotic fidelity and ensures balanced chromosome segregation.
Heterochromatin assembly at centromeres facilitates both kinet-
ochore formation and sister chromatid cohesion [6]. Furthermore,
the formation of chromatin structures at telomeres also serves to
maintain the length of telomere repeats [7]. Studies in fission yeast
showed that interaction between 3MeH3K9 and Swi6/HP1 is
required for chromosome segregation in mitosis [8]. In mammals,
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regions and pronounced 3MeH3K9 at pericentric heterochroma-
tin. Knockout of Suv39h1 and Suv39h2 in mouse results in
widespread genomic instability and increased incidence of
lymphomas, suggesting that 3MeH3K9 is a critical modification
to maintain chromosomal environments [2]. 2MeH3K9 has also
been implicated in DNA-methylation associated gene silencing [9–
11], but the enzyme control of this event has not been defined.
Cancer cells are characterized by prominent epigenetic
dysregulation, including altered chromatin modification. Previ-
ously we found increased level of G9a in human cancers [12],
although the functional role of the HMTs overexpression in cancer
remains unclear. Here, we show that knockdown (KD) of G9a and
SUV39H1 in cancer cells remarkably inhibited cell growth and led
to morphologically senescent cells with telomere abnormalities.
We found that G9a KD but not SUV39H1 KD induces extensive
chromosome instability and centrosome disruption. These data
suggest that G9a as well as SUV39H1 are required to maintain the
malignant phenotype and could be valid therapeutic targets in
human neoplasia.
Materials and Methods
Cell Lines, Culture Conditions and Drug Treatment
The prostate cancer cell line PC3, the lung cancer cell line
H1299 and the breast cancer cell line MCF7 were obtained from
the American Type Culture Collection (Manassas, VA). They
were grown in RPMI medium (Invitrogen, Carlsbad CA), plus
10% FBS in plastic tissue culture plates in a humidified
atmosphere containing 5% CO2 at 37uC. Cells were split 12–
24 h before 5-Aza-29-deoxycytidine (DAC, Sigma, St. Louis, MO)
treatment. Cells were then treated with either 1 mM of DAC, or
PBS (control) daily for 3 days.
RNA Interference
We designed a retrovirus vector (RNAi-Ready pSIREN-RetroQ
Vector, BD Biosciences) encoding a small hairpin RNA (shRNA)
directed against G9a and SUV39H1 in PC3 (target sequences of
59-AAGATTGAGCCTCCGCTGATT-39 and 59-AATCT-
CAAGTGTGTGCGTATC-39 for G9a and SUV39H1, respec-
tively). As a control, we used shRNAs for Luciferase (Luc)
synthesized by BD Biosciences or shRNA vector without hairpin
oligonucleotides.
Chromatin Immunoprecipitation (ChIP)
ChIP assays were performed based on a modification of
previously published methods [13]. Briefly, cells are treated with
1% formaldehyde for 8 min to crosslink histones to DNA. Cell
pellets are resuspended in lysis buffer and sonicated 8 sec seven
times. The lysate is incubated with 10 ml of anti-K4 dimethylated
histone H3, anti-K9 acetylated histone H3, anti-K9 dimethylated
histone H3 (Upstate Biotechnology, Charlottesville, VA) and anti-
histone H3 antibody (as an internal control, Abcam, Cambridge,
UK) at 4uC overnight. Two % of total lysate is used for input
control. DNA is extracted by the phenol/chloroform method,
ethanol-precipitated, and resuspended in water. ChIP products
were used for quantitative PCR with the oligonucleotide primers
described in Table S1. For quantitation, TaqMan Q-PCRs were
performed in an ABI Prism 7000 instrument (Applied Biosystems,
Foster City, CA) in duplicate for the target genes.
Immunoblotting
Immunoblotting was performed with primary antibodies for
anti-G9a (Abcam), anti-SUV39H1, anti-K9 dimethylated histone
H3, anti-K9 trimethylated histone H3 (Upstate Biotechnology),
histone H3 (Abcam) and ß-actin (Sigma).
RT-PCR Analyses
Total RNA was isolated using TRIzol (Invitrogen), and 2 mg
was reverse transcribed with MLV-reverse transcriptase (Invitro-
gen). The primer sequences used are described in Table S1. The
PCR protocol for RT-PCR was 95uC for 4 min, followed by 35
cycles of 30 sec at 95uC, 30 sec at 55uC and 30 sec at 72uC, and
then a 5 min final extension at 72uC. TaqMan Q-PCRs were
carried out in duplicate for the target genes G9a, SUV39H1 and
GAPDH using probe sets Hs00198710_m1, Hs00162471_m1 and
Hs 00266705_gl, respectively (Applied Biosystems).
Bisulfite Pyrosequencing Methylation Analysis
We performed bisulfite treatment as reported previously [14].
Briefly, 2 mg of genomic DNA were denatured with 2 M NaOH
for 10 min, followed by incubation with 3 M sodium bisulfite
(pH 5.0) for 16 h at 50uC. After treatment, DNA was purified
using a Wizard Miniprep Column (Promega, Madison, WI),
precipitated with ethanol, and resuspended in 30 ml of diluted
water. We used a highly quantitative method to assess DNA
methylation levels based on Pyrosequencing technology [15]
(Pyrosequencing AB, Uppsala, Sweden). Primer sequences are
described in Table S1.
SA-ß-gal Analysis
PC3 cells infected with retrovirus encoding G9a-shRNA,
SUV39H1-shRNA or control-shRNA were examined for SA-ß-
gal activity as previously described [16].
RNA Microarray Analysis
Total RNA was extracted from cells infected with either G9a-
shRNA, SUV39H1-shRNA or control-shRNA as described above.
Targets for microarray hybridization were generated from the
RNA according to the manufacturer’s instructions (Affymetrix,
Santa Clara, CA). The human U133A gene chip (Affymetrix)
which contains ,33,000 transcripts was used for gene expression
profiling. Hybridization, washing, scanning, and analysis of gene
chips were performed according to the manufacturer’s instruc-
tions. Expression levels were analyzed by the statistical algorithm
in the Microarray Analysis Suite (MAS) 5.0 software (Affymetrix)
using the default parameters. The data from the control-shRNA
treatment and parental PC3 were used as a baseline expression for
comparison with either G9a-shRNA or SUV39H1-shRNA treated
sample.
Measurement of Telomerase Activity
Telomerase activity was analyzed by a modified method of the
standard telomerase repeat amplification protocol (TRAP), the
TRAPeze Telomerase Detection Kit (Millipore, Billerica, MA)
according to the manufacturer’s instructions. Reaction products
were run on a 15% native polyacrylamide gel and stained with
ethidium bromide.
Immunofluorescence Cytogenetic
G9a-shRNA, SUV39H1-shRNA or control-shRNA treated
PC3 cells were grown on Falcon culture slides (Becton, Dickinson
and Company, Franklin Lakes, NJ). Anti-CENP-A monoclonal
antibody (Abcam), anti-K9 dimethylated histone H3 and anti-K9
trimethylated histone H3 polyclonal antibodies (Upstate Biotech-
nology) were used as primary antibodies. Centrosomes were
detected with a c-tubulin polyclonal antibody (Sigma) using a
Roles of G9a in Cancers
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Alexa Fluor 488 conjugate goat anti-mouse antibody (Invitrogen),
Alexa Fluor 546 conjugate goat anti-rabbit antibody (Invitrogen)
or fluorescein-conjugated goat anti-rabbit antibody (Sigma) and
the cells were counterstained with 49,6-diamidino-2-phenylindole
(DAPI), and embedded in anti-fade solution (200 mM DABCO,
90% vol/vol glycerol, 20 mM TRIS-HCl, pH8) to reduce photo-
bleaching. Scoring of cells and digital image acquisition were
performed using a 636 objective mounted on a Leica DMRBE
microscope (Leica, Wetzlar, Germany) equipped with optical
filters for DAPI and FITC (Chroma Technologies, Brattleboro,
VT) and a cooled charge coupled device (CCD) camera
(Photometrics, Tucson, AZ). The IPLab software package
(Scanalytics Inc, Fairfax, VA) was used for image acquisition
and processing. For each of the 3 cell preparations (control, G9a-
shRNA or SUV39H1-shRNA treated cells), 100 nuclei were
scored by two independent observers.
Telomere Length Analysis
G9a-shRNA, SUV39H1-shRNA or control-shRNA-treated
PC3 cells were evaluated for telomere shortening using the Telo-
FISH method to visualize telomeres in interphase cell populations,
as described previously [18]. Briefly, FISH analysis was performed
using a commercially available Cy3-conjugated peptide nucleic
acid (PNA) telomeric probe per the manufacturer’s (DAKO
Corporation, Carpinteria, CA) instructions. Independent analysis
was performed by two blinded observers using a Leica DMRBE
microscope equipped with a Cy3 and 49,6-diamidino-2-phenylin-
dole (DAPI) filters. More than 100 interphase nuclei were visually
evaluated, and digital images were obtained using a cooled CCD
(charge coupled device) camera.
Results
To evaluate the role of SUV39H1 and G9a in cancers, first we
established clones of PC3, in which either of these 2 HMTs were
stably downregulated by shRNA. We used PC3, since endogenous
SUV39H1 and G9a were highly expressed in this cell. In these
knockdown (KD) clones, expression of the 2 HMTs was reduced
by 80–90% (Figs. 1A and 1B). KD cells for G9a (G9a-KD) showed
reduction of overall 2MeH3K9 and 3MeH3K9. KD cells for
SUV39H1 (SUV-KD) reduced overall 3MeH3K9 but no
remarkable change on 2MeH3K9 (Fig. 1B). 2MeH3K9 was
broadly detected in nuclei of control cells including eu- and
heterochromatic region (Fig. 1C). However, the G9a-KD cell
nucleus showed selectively impaired broad euchromatic staining of
2MeH3K9 and contained only blurred speckles, which were
overlapping with the pericentric region (densely stained with
DAPI) and centromeric region (stained with CENP-A). 3MeH3K9
was detected on the pericentric region and centromeric region in
control cells. SUV-KD cells showed diminished 3MeH3K9, but
not completely, at the heterochromatic foci and did not
significantly alter the 2MeH3K9 states (Fig. 1C). G9a-KD did
not significantly affect 3MeH3K9 patterns of the pericentric
region and centromeric region. These findings were consistent
with the previous G9a- deficient ES cell studies [19,20].
Interestingly, it appeared that G9a-KD affected H3K9me3 status
at euchromatic region.
Both SUV-KD and G9a-KD showed markedly inhibited cell
growth and profound morphological changes, enlarged and
flattened shapes. (Figs. 1D and 1E). Senescence associated ß-
galactosidase analysis (SA-ß-gal analysis) demonstrated that this
morphological change was consistent with induction of cellular
senescence.
Induction of cellular senescence in response to stimuli depends
primarily on the p53 or p16-pRB pathways [21]. Since p16 is
silenced by DNA methylation in PC3 and its p53 status is null, we
next examined p16 reactivation in the G9a-KD and SUV-KD
cells. By contrast to treatment with the DNA methyltransferase
inhibitor 5-aza-29-deoxycytidine (DAC), we found p16 activation
in neither the G9a-KD nor the SUV-KD cells, consistent with no
effect on epigenetic status of the promoter region (Fig. 2). We also
examined another tumor suppressor gene, RASSF1A, which is a
target of DNA methylation in PC3, and found that there was no
effect on gene reactivation in either the G9a-KD or the SUV-KD
cells. Given that DNA methylation, a crucial epigenetic mecha-
nism for silencing tumor suppressor genes in human neoplasia, has
been mechanistically linked to histone 2MeH3K9 methylation [9–
11], these data could be explained by compensation by other
HMTs.
To examine target genes of H3K9 methylation dependent
silencing by either G9a or SUV39H1, we analyzed genes up-
regulated after inhibition of G9a or SUV39H1 using oligonucle-
otide microarrays. In analyzing the array data, first we selected
genes with signal intensities of 50 or less in either parental or
control shRNA-treated PC3 (i.e. silenced genes). Then we
searched for genes with signal intensities increased more than 2
times after KD of either G9a or SUV39H1. After removal of self-
inconsistent probes among the same gene, we could identify only 4
and 6 genes (3 genes are common) in the G9a-KD and the SUV-
KD cells, respectively. We examined those 7 genes by RT-PCR
and found that only 2 genes, Klotho and growth differentiation factor 8
(GDF8), were truly silenced in the control cells and up-regulated in
both G9a-KD and SUV-KD cells (data not shown). Thus, very
few genes are up-regulated after inhibition of the 2 HMTs in PC3.
Although, G9a and SUV39H1 are generally involved in gene
silencing, we found that 12 and 2 genes (2 genes were common)
were down-regulated in the G9a-KD and the SUV-KD cells,
respectively (Table S2). Down-regulation of those few genes might
be due to the secondary effects of G9a-KD and the SUV-KD.
Despite minimal effects on gene expression, markedly inhibited
cell growth was observed in both the G9a-KD and the SUV-KD
cells. We examined these cells by FACS analyses to determine the
mechanism involved. We found that the G9a-KD cells showed
increased DNA content (1.7-fold in 2 independent clones) and the
SUV-KD cells evidenced substantial increases in G2/M fraction
(from 29% to 40%) compared to the control (Fig. 3A). Consistent
with these data, karyotype analyses (Fig. 3B) revealed an increased
number of chromosomes in the G9a-KD cells compared to the
SUV-KD cells and the parental PC3 cell line (Fig. 3B). Numbers
of the chromosome were counted in more than 8 nucleus of each
KD cell (Fig. 3B). G9a-KD cells showed significantly increased
chromosome numbers (average, 119 chromosomes, P,0.01) than
the SUV-KD cells (63 chromosomes) and control cells (65
chromosomes). This was true regardless of the cell line types used.
Both stable G9a-KD clones of the breast cancer cell line MCF7
and the lung cancer cell line H1299 also showed an increased
number of chromosomes compared to control cells (MCF7-control
vs MCF7-G9a-KD, 60 chromosomes vs 98 chromosomes; H1299-
control vs H1299-G9a-KD, 72 chromosomes vs 104 chromo-
somes; Figure S1).
Centrosomes are essential for proper cellular polarity and
balanced distribution of chromosomes [22]. We used an antibody
against c-tubulin to evaluate the centrosomes in the KD cells.
Although the majority of the cells in both control and G9a-KD
showed normal (1 to 2) centrosome numbers, we detected
centrosome amplification in about 25% of the cells in the G9a-
KD cells. This was not detected in the control cells and SUV-KD
Roles of G9a in Cancers
PLoS ONE | www.plosone.org 3 April 2008 | Volume 3 | Issue 4 | e2037Figure 1. Effects of histone methyltransferases, either G9a or SUV39H1 knockdown (G9a-KD or SUV-KD, respectively). Real-time PCR
(A) and Western blotting (B) show that shRNA interference effectively downregulates G9a or SUV39H1 expression. Error bars in real-time PCR indicate
standard deviation of the expression in more than 3 independently-isolated clones. Regarding H3 modifications, the G9a-KD (2 independent clones)
cells show reduction of overall 2MeH3K9. By contrast, SUV-KD reduced overall 3MeH3K9 but no remarkable change on 2MeH3K9. C, H3-K9
methylation states were analyzed by immunofluorescence with 2MeH3K9 (red, left) or 3MeH3K9 (red, right) specific antibodies in control cells (Ctrl),
G9a-KD cells or SUV-KD cells. 2MeH3K9 was broadly detected in control nuclei. The G9a-KD nucleus revealed faint speckles of 2MeH3K9 overlapping
with DAPI-dense (blue) loci and the CENP-A staining (green). which represent the pericentric region and centromeric region, respectively. SUV-KD
reduced 3MeH3K9 at the heterochromatic foci and did not significantly alter the euchromatic staining of 2MeH3K9 states. Cell size is relative to the
10-mm bar. D, G9a-KD and SUV-KD result in strong growth inhibition. Cells were plated at the same density and counted daily by Trypan blue
exclusion. Filled circles, filled triangles and filled squares indicate the growth of the control, the SUV-KD and the G9a-KD cells, respectively. Error bars
on the graph indicate the standard deviation from triplicate experiments. E, Downregulation of two histone methyltransferases result in a remarkable
morphologic change, which is stained positively for SA-beta-gal, indicating induction of senescence. Cell size is relative to the 50-mm bar.
doi:10.1371/journal.pone.0002037.g001
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MCF7-G9a-KD cells and H1299-G9a-KD cells in around 20% of
the cells (Figure S1). Thus, G9a might play a critical role in
regulating centrosome duplication, presumably through chromatin
structure rather than by affecting gene expression in cancer cells.
The chromatin structure at telomeres is also important to
maintain the length of telomere repeats [7]. We investigated
telomere function in the G9a-KD and the SUV-KD cells. First, we
used telo-FISH assay to evaluate telomere length. Significant
reduction in the telomere signal intensity was observed in the G9a-
KD and SUV-KD treated PC3 cells, as compared to the control
cells suggesting that regulation of telomere length was disrupted in
these KD cells. A representative example of the decrease in the
telomere signal is shown in figure 4A. We next quantified
telomerase activity in those cells by the TRAP assay and found
reduction of telomerase activity in the G9a-KD cell line (Fig. 4B).
Therefore, the shortened telomere length in the G9a-KD cells
might be the result of altered telomerase activity. The decreased
level of hTERT expression in the G9a-KD cells lends support to
these findings (Fig. 4C). In contrast, the SUV-KD cells showed
similar levels of telomerase activity to the control cells, indicating
that telomere dysfunction in the SUV-KD cells might depend on
mechanisms other than hTERT expression, probably due to
alterations of H3K9 methylation status at telomeric heterochro-
matin.
Dsicussion
The current study demonstrates that expression of SUV39H1
and G9a is important to support the growth of malignant cells,
although they play distinct roles in cancer cells. Unexpectedly,
very few genes are up-regulated after inhibition of the 2 HMTs,
suggesting that H3K9 methylation associated silencing, which has
been mechanistically linked to DNA methylation [9–11], is stable
once it is established in cancer cells, possibly through the action of
multiple HMTs.
Centromere mediates multiple segregation functions, including
kinetochore formation, spindle-mediated movements, sister cohe-
sion and a mitotic checkpoint [6]. The pericentric heterochroma-
tin architecture plays crucial roles in chromosomal segregation as
well as in establishing transcriptional repression. The loss of
Suv39h1 and Suv39h2 HMTases in mouse model abolished H3-
K9 methylation at pericentric heterochromatin and induced
chromosomal instability. However, single gene disruptions for
either Suv39h1 or Suv39h2 did not appear to affect viability and
fertility of mutant mice, suggesting these two enzymes are
redundant [2]. Study in G9a knockout mouse showed that G9a
was necessary for embryonic development or differentiation and
embryonic growth defect in G9a-deficient ES cells might be due to
apoptotic cell death but not cell cycle arrest. In that model,
chromosomal instability was not perceived in the knockout cells
Figure 2. Neither G9a nor SUV39H1 knockdown affects gene expression and epigenetic states of p16 and RASSF1A. A, RNA
expression of each gene was examined by RT-PCR. In contrast to 5-Aza-29-deoxycytidine (DAC) treatment, neither G9a-KD nor SUV-KD reactivates p16
and RASSF1A expression. p21 and GAPDH are used for active gene controls. B, DNA methylation changes on the p16 and the RASSF1A promoters
were analyzed by the pyrosequencing quantitative method. Consistent with the expression status for both genes, DNA methylation is decreased by
DAC treatment, whereas no changes are observed in either G9a-KD or SUV-KD cells. Error bars on the graph indicate the standard deviation from
triplicate experiments. C, Histone modifications studied by ChIP are indicated below the columns. K4Me, K9Ac, K9Me and Ab(-) indicates K4
dimethylation, K9 acetylation, K9 dimethylation and no antibody control, respectively. The y axis represents the ratio of each IP to a core histone H3
immunoprecipitation. Black bars, white bars and gray bars indicate the ChIP from the mock control, the G9a-KD and the SUV-KD cells, respectively.
p21 was used as an active gene control, in which active histone marks, K4Me and K9Ac, are high. Error bars on the graph indicate the standard
deviation from triplicate experiments.
doi:10.1371/journal.pone.0002037.g002
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PLoS ONE | www.plosone.org 5 April 2008 | Volume 3 | Issue 4 | e2037Figure 3. Downregulation of G9a methyltransferase induces genomic instability. A, FACS analyses showing DNA content is increased 1.5–2
times in the G9a-KD cells compared to the mock control in two independently-isolated clones (G9a-C1 and -C2). The SUV-KD cells show a high
amount of G2M cells compared to the mock control. B, karyotype analyses showed 61, 102 and 61 chromosomes in the control PC3, the G9a-KD and
the SUV-KD cell lines, respectively. Chromosome number is remarkably increased in the G9a-KD cells. Numbers of the chromosome were counted in
more than 8 nucleus of each KD cell. G9a-KD cells showed significantly increased chromosome numbers than the SUV-KD cells and control cells. Y axis
indicates number of chromosome. Error bars indicate standard deviation. *, P,0.01. C, Nuclei were stained with DAPI. Centrosomes were detected
using an antibody against c-tubulin. In the control cells and SUV-KD cells, 1–2 centrosomes appearing as point-like structures are seen in each cell. In
the G9a-KD cells, abnormal centrosome morphology and number, suggestive of centrosome amplification was observed in about 25% of the cells.
Abnormally amplified centrosomes are magnified in the boxes.
doi:10.1371/journal.pone.0002037.g003
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aberrant numbers of chromosome, G9a KD induced centrosome
disruption and more extensive chromosome instability, which
resulted in inhibition of cell growth and cellular senescence. It
appeared that 3MeH3K9 was also diminished at euchromatic
region in the G9a KD cells. This might be due to the drastic
decreasing of 2MeH3K9, which is prerequisite for modification of
tri-methylation on the loci. These data suggested that the role of
G9a in cancer cells is critical and appears to be protecting further
chromosomal disruption. By contrast, single Suv39H1 KD
partially abolished 3MeH3K9 at pericentric region but could
not induce chromosomal instability, probably due to redundant
roles for SUV39H HMTases [2].
Recent reports demonstrated that centromeric chromatin
specific combinations of histone modifications and the three-
dimensional organization of chromosomes could also be important
for recruitment of cohesion complexes to heterochromatin near
sister kinetochores [23] [24]. 2MeH3K9 chromatin, which is
present in the inner kinetochore space between mitotic sister
chromatids and in regions that flank centromeric chromatin, could
be attributable to the position of CENP-A toward the poleward
face of the mitotic chromosome [25]. The decreased level of
2MeH3K9 on the flanking region of centromere chromatin by
G9a KD might affect the three-dimensional organization of
centromere chromosomes, resulting in the chromosomal instability
we found here.
Centrosomes start to duplicate at the late G1/early S phase of
the cell cycle, and two functional centrosomes are formed during
G2 [22]. If cells fail to undergo cytokinesis after DNA synthesis
and the next cell cycle resumes, they might have twice the normal
DNA content and centrosome number. Thus, the current data
suggested that failure in cytokinesis might be an explanation for
the abnormalities in chromosomal number and centrosomes in the
G9a-KD cells.
G9a appears to be required for hTERT expression and
telomere maintenance. SUV39H1 is also required for control
telomere regulation. In mouse model, embryonic fibroblast from
mice null with both Suv39h1 and Suv39h2 showed abnormal
telomere elongation [26]. Abrogation of the two HMTs resulted in
loss of heterochromatic features at telomeres in embryonic stem
Figure 4. Disruptions of telomere function in the G9a-KD and the SUV-KD cells. A, Interphase nuclei were hybridized with Cy3-conjugated
peptide nucleic acid (PNA) telomeric probe and counterstained with DAPI. Marked reduction in the telomere signal is observed in interphase nuclei
from KD cells as compared to the nuclei from the control line. Shown in the insets are the enlarged images of the indicated areas. B, Telomerase
activity is assessed by TRAP assay. Samples with telomerase activity produce a 6-base incremental ladder of TRAP products on the gels. Internal
control bands appear at the bottom of the gel. A reduced signal intensity of telomerase activity is observed in the G9a-KD cell lines. The signal is not
observed when the extracts are pretreated with heat to abolish the protein components of telomerase, suggesting the telomerase specificity of the
signal measured by this assay. C, Expression level of hTERT was measured by real-time PCR. hTERT expression is decreased in the G9a-KD cells
compared to those in the control PC3 and the SUV-KD cells. Error bars indicate standard deviation of the 3 independent assays.
doi:10.1371/journal.pone.0002037.g004
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SUV39H1 KD in cancer cells have shorter telomeres. The reasons
why we found the shortening of the telomeres in SUV39KD cells
by contrast to the previously results might be due to the cell types
studied (i.e. normal cells versus cancer cells), since telomere
function was generally aberrantly regulated in cancer cells [27].
Further studies need to address the mechanistic links between
G9a, SUV39H1 and chromosomal/telomere structures as well as
hTERT expression in cancer cells. It also might be interesting to
see whether the individual effects of G9a and SUV39H1 are
cooperative when they are both depleted, and whether reintro-
duction of the two HMTs reverts the phenotype. Nevertheless,
targeting these histone methyltransferases could be of therapeutic
benefit in cancer treatments.
Supporting Information
Figure S1 Downregulation of G9a methyltransferase in MCF7
and H1299 cell lines. A, Real-time PCR shows that shRNA
interference effectively downregulates G9a in MCF7 and H1299.
Error bars in real-time PCR indicate standard deviation of the
expression in 3 independently isolated clones. B, FACS analyses
showing DNA content is increased 1.5–2 times in the G9a-KD
cells compared to the mock control in an isolated clone. Increased
DNA content was observed in two independently-isolated clones
(data not shown). C, karyotype analyses showed small and
increased chromosomes in both MCF7-G9a-KD and H11299-
G9a-KD cell lines. D, Centrosomes were detected using an
antibody against c-tubulin. In the control cells, 1–2 centrosomes
appearing as point-like structures are seen. Abnormal centrosome
morphology and number are observed in around 20% of the G9a-
KD cells.
Found at: doi:10.1371/journal.pone.0002037.s001 (2.67 MB EPS)
Table S1 Summary of the primers
Found at: doi:10.1371/journal.pone.0002037.s002 (0.04 MB
DOC)
Table S2 List of up-regulated and down-regulated genes in G9a-
KD or SUV39H1-KD
Found at: doi:10.1371/journal.pone.0002037.s003 (0.05 MB
DOC)
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